Immunization delivery cost estimates help with resource allocation and budgeting for countries. However, many low- and middle-income countries (LMICs) do not have immunization delivery unit cost estimates available or have estimates that are uncertain, unreliable, or old. A newly published study on immunization delivery cost provides valuable analysis and fills a critical data gap by producing cost estimates for 136 LMICs.
The study, led by Harvard in collaboration with ThinkWell and Management Sciences for Health and funded by the Bill & Melinda Gates Foundation, aims to inform and improve decision-making, progress monitoring, financial sustainability, and coverage and equity of immunization programs. Utilization of the findings of this evaluation will not only inform key immunization decision-makers and planners at the country level but also has the potential to advance progress towards achieving 14 of the 17 Sustainable Development Goals (SDGs) to which routine immunization is a critical factor.
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.